The case series found consistent improvements in outcomes, demonstrating a unique use in management of MS symptoms AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- A case series conducted by Dr. Courtney ...

AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- A case series conducted by Dr. Courtney Ellerbusch, PT, DPT, of Centura Home Health (Colorado) on MS patients finds quantitative improvements in strength, ...

Medicinal cannabinoids are helpful for treatment of spasticity, pain, and bladder dysfunction for patients with multiple sclerosis (MS), although their efficacy is "limited," new research suggests.

WILMINGTON, N.C.--(BUSINESS WIRE)--Osmotica Pharmaceutical announced today that recruitment has begun for a Phase 3 clinical trial designed to assess the safety and efficacy of Arbaclofen Extended ...

LONDON, July 28 (Reuters) - GW Pharmaceuticals Plc's cannabis-derived medicine Sativex has been approved in its second European market, Spain, as an add-on therapy for treating spasticity in patients ...

A study published in the Journal of Clinical Medicine indicated that vaporized cannabis containing standardized percentages of cannabidiol (CBD) and tetrahydrocannabinol (THC) produced sustained ...

The nerve damage caused by multiple sclerosis (MS) can disrupt a person’s ability to walk, balance, and even carry out the most basic everyday activities. Staying physically active can improve sleep ...